SCHEMBL4667871

SCHEMBL4667871

CCOc1cccc(-c2cc(N)n(-c3cscc3C)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.44
MAPT P10636 5/20 0.43
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
NPC1 O15118 1/20 0.43
NFKB1 P19838 1/20 0.43
RAB9A P51151 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
BRD4 O60885 1/20 0.42
BRD2 P25440 1/20 0.42
CREBBP Q92793 1/20 0.42
NPSR1 Q6W5P4 2/20 0.40
GAA P10253 1/20 0.40
MAP4K4 O95819 1/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24378643 0.69 KMT2A (0.51) NOTUMMAPTALDH1A1SMN1; SMN2BRD4
SCHEMBL19626484 0.67 TSHR (0.57) NOTUMMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL3631400 0.67 FGFR1 (0.54) NOTUMMAPTALDH1A1SMN1; SMN2RAB9A
SCHEMBL30963937 0.66 RXRA (0.51) NOTUMMAPTBRD4BRD2CREBBP
SCHEMBL4667063 0.66 ALDH1A1 (0.61) MAPTALDH1A1SMN1; SMN2NPC1NFKB1
SCHEMBL9260410 0.66 RXRA (0.66) NOTUMMAPTALDH1A1SMN1; SMN2RAB9A
SCHEMBL29426410 0.66 RXRA (0.66) NOTUMMAPTALDH1A1SMN1; SMN2RAB9A
SCHEMBL11523724 0.66 NOTUM (0.52) NOTUMMAPTSMN1; SMN2BRD4BRD2
SCHEMBL17626237 0.66 MAPT (0.49) NOTUMMAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL26253637 0.65 TP53 (0.44) NOTUMMAPTALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed